Gladstone NOW: The Campaign Join Us on the Journey ✕
346 - 360 of 1364 Results Clear All
Study suggests that targeting a protein in the thalamus could block the long-term damage that follows brain injuries
News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz Lab
Gladstone scientists uncover novel aspects of HIV infection by monitoring sugars at the surface of individual immune cells
News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab
ABC7 News—As Omicron BA.4 and BA.5 variants overtake previous coronavirus variants across the United States, Gladstone Associate Investigator Nadia Roan, PhD, explains that their success may owe both to their ability to escape our immune system and to their accelerated replication rate. She suggests that more effort should be made to block infection at the level of the airways, the virus's entry point into our body.
Gladstone Experts COVID-19 Roan Lab
A science educator describes how their mentor impacted their career
Profile Diversity
Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
The new study paves the way toward more effective cancer immunotherapies
News Release Cancer Genomic Immunology Marson Lab
Cancer Research Institute—The Cancer Research Institute recently announced its newest cohort of Scientists Taking Risks (STAR) funding for high risk/high reward research in tumor biology. Of the six recipients, three are core members of the Gladstone-UCSF Institute of Genomic Immunology: Kole Roybal, Ansuman Satpathy, and Matthew Spitzer.
Awards Gladstone Experts Genomic Immunology
Graduate Student Will Flanigan shares the importance of LGBTQ+ representation in STEM
LGBTQ Jain Lab Shipman Lab
A graduate diversity officer suggests ways organizations can be more inclusive of LGBTQ+ scientists
Profile Diversity
San Francisco Chronicle—A year has passed since California dropped most public health restrictions related to COVID-19, but the pandemic isn’t over. Senior Investigator Warner Greene notes that the virus is still spreading effectively, and people can be infected repeatedly with different subvariants.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
Postdoctoral researcher Yuliya Voskobiynyk spurs action to support Ukraine at Gladstone and beyond
Graduate Students and Postdocs Institutional News Paz Lab
A high school science teacher describes why it’s important to be out in science
Profile Diversity
Get to know one of the panelists from the 2022 Out in Science event
Profile Diversity
San Francisco Chronicle—A study in the Mission District of San Francisco tracked how COVID-19 symptoms have changed over the course of the pandemic. Gladstone virologist Nadia Roan explains that the Omicron variant infects the upper respiratory tract and triggers a localized immune response, which may in part explain why individuals infected during the Omicron wave were less likely to experience severe illness.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
Washington Post—Even as COVID restrictions are easing, case numbers are rising around the country. Melanie Ott, director of the Gladstone Institute of Virology, explains that recent research from her group shows that individuals infected with the Omicron variant have limited natural immunity, and may still be susceptible to infection with Omicron subvariants.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
